Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing.

Authors

Mini Kamboj
Jennifer Brite
Anoshe Aslam
Jessica Kennington
N Esther Babady
David Calfee
Yoko Furuya
Donald Chen
Michael Augenbraun
Belinda Ostrowsky
Gopi Patel
Monica Mircescu
Vivek Kak
Roman Tuma
Teresa A Karre
Deborah Fry MT (ASCP), MBA, CIC, Lehigh Valley Health NetworkFollow
Yola P Duhaney
Amber Moyer RN, BSN, CNRN, Lehigh Valley Health Network
Denise Mitchell
Sherry Cantu
Candace Hsieh
Nancy Warren
Stacy Martin
Jill Willson
Jeanne Dickman
Julie Knight
Kim Delahanty
Annemarie Flood
Jennifer Harrington
Deborah Korenstein
Janet Eagan
Kent Sepkowitz

Publication/Presentation Date

3-1-2018

Abstract

In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.

Volume

24

Issue

3

First Page

584

Last Page

587

ISSN

1080-6059

Published In/Presented At

Kamboj, M., Brite, J., Aslam, A., Kennington, J., Babady, N. E., Calfee, D., & ... Sepkowitz, K. (2018). Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing. Emerging Infectious Diseases, 24(3), 584-587. doi:10.3201/eid2403.170961

Disciplines

Infectious Disease

PubMedID

29460760

Department(s)

Department of Medicine, Department of Medicine Faculty

Document Type

Article